Literature DB >> 32759960

Non-invasive prenatal testing (NIPT): societal pressure or freedom of choice? A vignette study of Dutch citizens' attitudes.

Adriana Kater-Kuipers1, Iris M Bakkeren2, Sam R Riedijk2, Attie T J I Go3, Marike G Polak4, Robert-Jan H Galjaard2, Inez D de Beaufort5, Eline M Bunnik5.   

Abstract

The introduction of the accurate and procedurally easy non-invasive prenatal test (NIPT) raises ethical concerns that public attitudes towards prenatal screening may change, leading to societal pressure to participate in aneuploidy screening. This study examined Dutch citizens' attitudes towards a pregnant woman's decision to (1) decline NIPT in the context of two different funding policies and (2) to terminate or continue a pregnancy affected by different disorders. The attitudes of 1096 respondents were assessed with the contrastive vignette method, using two pairs of vignettes about declining NIPT and termination of pregnancy. Most respondents either agreed with a woman's decision to decline NIPT or were neutral about it, stating that this decision should be made independently by women, and does not warrant judgement by others. Interestingly, funding policies did influence respondents' attitudes: significantly more respondents disagreed with declining NIPT when it was fully reimbursed. Respondents had similar attitudes to the vignettes on termination and continuation of pregnancy in case of Down's syndrome. In case of Edwards' or Patau's syndrome, however, significantly more respondents disagreed with continuation, citing the severity of the disorder and the child's best interests. This study demonstrates broad acknowledgement of women's freedom of choice in Dutch society; a finding that may help to rebut existing concerns about societal pressure for pregnant women to participate in prenatal screening. As the reimbursement policy and the scope of NIPT may influence people's attitudes and elicit moral judgements, however, maintaining freedom of choice warrants sustained efforts by health professionals and policy makers.

Entities:  

Mesh:

Year:  2020        PMID: 32759960      PMCID: PMC7853136          DOI: 10.1038/s41431-020-0686-9

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  4 in total

1.  Patient experience with non-invasive prenatal testing (NIPT) as a primary screen for aneuploidy in the Netherlands.

Authors:  Syanni A Kristalijn; Karen White; Deanna Eerbeek; Emilia Kostenko; Francesca Romana Grati; Caterina M Bilardo
Journal:  BMC Pregnancy Childbirth       Date:  2022-10-20       Impact factor: 3.105

2.  Routinization of prenatal screening with the non-invasive prenatal test: pregnant women's perspectives.

Authors:  Karuna R M van der Meij; Annabel Njio; Linda Martin; Janneke T Gitsels-van der Wal; Mireille N Bekker; Elsbeth H van Vliet-Lachotzki; A Jeanine E M van der Ven; Adriana Kater-Kuipers; Danielle R M Timmermans; Erik A Sistermans; Robert-Jan H Galjaard; Lidewij Henneman
Journal:  Eur J Hum Genet       Date:  2021-08-13       Impact factor: 5.351

3.  Non-invasive prenatal test uptake in socioeconomically disadvantaged neighborhoods.

Authors:  Karuna R M van der Meij; Caroline Kooij; Mireille N Bekker; Robert-Jan H Galjaard; Lidewij Henneman
Journal:  Prenat Diagn       Date:  2021-09-14       Impact factor: 3.242

4.  Does non-invasive prenatal testing affect the livebirth prevalence of Down syndrome in the Netherlands? A population-based register study.

Authors:  Maurike de Groot-van der Mooren; Gert de Graaf; Michel E Weijerman; Mariette J V Hoffer; Jeroen Knijnenburg; Anne-Marie M F van der Kevie-Kersemaekers; Angelique J A Kooper; Els Voorhoeve; Birgit Sikkema-Raddatz; Laura J C M van Zutven; Malgorzata Ilona Srebniak; Karin Huijsdens-van Amsterdam; John J M Engelen; Dominique Smeets; Anton H van Kaam; Martina C Cornel
Journal:  Prenat Diagn       Date:  2021-07-01       Impact factor: 3.050

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.